Medicare Lead Vendor Due Diligence Checklist for Agencies

Your agency's growth depends on a steady flow of qualified Medicare prospects, but the wrong lead vendor can drain your budget, expose you to regulatory risk, and damage your reputation with carriers. The stakes are high: a single TCPA violation can trigger six-figure penalties, and leads that lack proper consent documentation can put your entire book of business at risk. That is why a structured due diligence process is not optional for agencies serious about scaling. This checklist walks you through the critical areas to evaluate before you sign a contract with any Medicare lead provider, from sourcing and consent to contract terms and pilot design.

Why Medicare Lead Vendor Due Diligence Matters for Agencies

Medicare lead generation operates in a heavily regulated environment. The Centers for Medicare and Medicaid Services (CMS) enforces strict marketing rules, and the Federal Communications Commission (FCC) enforces the Telephone Consumer Protection Act (TCPA). When you purchase leads from a vendor, you inherit a degree of liability if those leads were generated improperly. Agencies that skip due diligence often discover too late that their vendor used deceptive landing pages, lacked proper consent language, or resold the same lead to dozens of buyers, diluting value and increasing compliance exposure.

Beyond risk, vendor quality directly impacts your closing rates and return on investment. A vendor that cannot provide references, sample leads, or clear documentation of lead sources is unlikely to deliver consistent results. Conversely, a vendor that invests in transparency, compliance, and lead validation becomes a strategic partner in your growth. The checklist below is organized around the questions and documents you should request before committing to any Medicare lead vendor.

Lead Sourcing and Consent Capture: The Foundation of Compliance

Start by asking how the vendor generates leads. Legitimate vendors should be able to describe their traffic sources in detail, including whether leads come from organic search, paid advertising, affiliate networks, direct mail, or inbound calls. Vague answers like "we have a network" are a red flag. You need to know exactly where the consumer information originates and whether the consumer took an affirmative action to request contact about Medicare plans.

Consent capture is equally critical. Under TCPA rules, a consumer must provide prior express written consent before receiving autodialed or prerecorded calls. Ask the vendor to show you the exact language displayed to consumers, along with the timestamp and IP address associated with each consent. The consent must be specific to Medicare marketing and must not be buried in unrelated terms of service. If the vendor cannot produce this documentation on demand, walk away.

Resale limits are another key area. Some vendors sell the same lead to multiple buyers, which can be acceptable if disclosed upfront, but you need to know how many times a lead will be resold and to whom. Ask whether the vendor has a cap on resale volume and whether they track which buyers have already contacted the consumer. A reputable vendor will have clear policies on lead exclusivity and resale frequency. For agencies exploring shared lead strategies, understanding these limits helps set realistic expectations for closing rates and competition.

To structure this part of your evaluation, use the following checklist items:

• Request a written description of all lead generation sources (paid search, social, affiliates, direct mail, inbound calls).
• Obtain the exact consent language shown to consumers, including any disclosures about Medicare marketing.
• Confirm that the vendor captures and stores TCPA-compliant consent records with timestamps and IP addresses.
• Ask for the vendor's policy on lead resale, including how many buyers receive each lead and whether resale volume is capped.
• Verify that the vendor excludes leads generated through incentivized or misleading offers.

Once you have this information, review it with your compliance team or legal counsel. A vendor that hesitates to share consent documentation or lead source details is not worth the risk, regardless of price.

Requesting Sample Leads and References Before You Commit

No matter how polished a vendor's sales pitch is, you need evidence of actual performance. Ask for a sample of recent leads in your target geography, including the data fields provided, the freshness of the leads, and the consumer's stated intent. Review the sample for accuracy: are phone numbers valid, are addresses correct, and do the consumers match your ideal prospect profile? A vendor that cannot provide a meaningful sample (at least 20 to 50 leads) is hiding something.

References are equally important. Request contact information for three to five current or recent agency clients who operate in a similar market or specialize in the same Medicare products you sell. When you speak with references, ask specific questions about lead quality, closing rates, vendor responsiveness, and how the vendor handles replacements or disputes. Vague praise like "they are fine" is less useful than concrete details about conversion rates and support experiences.

If possible, ask references whether they have ever experienced a compliance issue tied to the vendor's leads and how the vendor responded. A vendor that stands behind its product and resolves issues quickly is worth considering. One that deflects blame or disappears when problems arise is a liability. For agencies exploring shared lead volume strategies, references can also shed light on how many competitors are contacting the same prospects and whether that competition is manageable.

Contract Terms: Replacement Policy, Exclusivity, and Billing

The contract is where good intentions meet reality. Before signing, scrutinize the replacement policy. What qualifies a lead for replacement? Common criteria include disconnected numbers, wrong numbers, duplicates, and consumers who deny requesting information. The policy should be written clearly, with a defined window for submitting replacement requests (for example, 48 to 72 hours) and a clear process for how replacements are issued. Avoid vendors that make replacement claims difficult or that require excessive documentation for every request.

Exclusivity terms deserve equal attention. If you are paying for exclusive leads, the contract should explicitly state that each lead is sold only once. If you are purchasing shared leads, the contract should disclose the maximum number of buyers per lead. Look for language that protects you from unexpected resale or from the vendor selling your lead to a direct competitor after you have already contacted the consumer. Billing terms should also be transparent: are you billed per lead, per call, or on a subscription basis? Are there minimum volume commitments or cancellation fees? Understand the payment schedule and whether refunds are available for invalid leads.

Finally, review the contract for data ownership and use rights. You should retain the right to contact the leads you purchase and to store their information in your CRM. The vendor should not claim ownership of your client relationships or restrict your ability to follow up. If any clause seems ambiguous, ask for clarification in writing before signing.

Data Security and TCPA Compliance Documentation

Medicare leads involve sensitive personal information, including names, addresses, phone numbers, and health-related details. Vendors must have robust data security practices to protect this information from breaches and unauthorized access. Ask about encryption (both in transit and at rest), access controls, and employee training on data protection. A vendor that cannot describe its security measures in detail is not equipped to handle your leads responsibly.

TCPA compliance documentation is non-negotiable. Request copies of the vendor's consent capture process, including the exact language and the mechanism for recording consent. Ask whether the vendor scrubs leads against the National Do Not Call Registry and whether it maintains internal do-not-call lists. The vendor should also have a process for handling opt-outs and for ensuring that consumers who request no further contact are removed from all marketing lists. If the vendor cannot produce this documentation, you are exposing your agency to significant legal risk.

Additionally, confirm that the vendor complies with CMS marketing guidelines. Medicare Advantage and Part D marketing have specific rules about how plans are presented and what information must be disclosed. A vendor that operates outside these rules can taint your entire lead flow. For a deeper dive into shared lead volume strategies for smaller agencies, see our guide on shared Medicare lead volume strategy, which explains how to balance volume and exclusivity while maintaining compliance.

Designing a Pilot Period and Setting Success Criteria

Even after you have reviewed sourcing, references, contracts, and compliance documentation, you should never commit to a large volume purchase without a pilot. A pilot period allows you to test lead quality, measure conversion rates, and evaluate the vendor's support in real time. Design the pilot to last at least 30 days, with a defined volume (for example, 50 to 100 leads) and a clear set of success metrics.

Define success criteria upfront. What closing rate would make the pilot a success? What percentage of leads should be valid (that is, reachable and interested)? What is the acceptable timeframe for replacements? How responsive is the vendor's support team? Track these metrics diligently during the pilot and compare them against your existing lead sources. If the pilot fails to meet your criteria, you have lost only a small investment rather than a large contract commitment.

During the pilot, also test the vendor's reporting and analytics. Can they provide detailed lead-level data, including source, consent timestamp, and outcome? Do they offer call tracking or CRM integration? A vendor that provides robust reporting makes it easier for you to optimize your campaigns and demonstrate ROI. For agencies seeking pay-per-call and lead generation solutions, platforms like Astoria Company offer performance marketing tools that include call tracking and fraud prevention, which can complement your vendor evaluation process.

If the pilot succeeds, negotiate a gradual ramp-up rather than an immediate jump to full volume. This allows you to maintain quality control and adjust your processes as you scale. If the pilot fails, document the reasons and use that information to refine your checklist for future vendors.

Putting the Checklist into Practice

A thorough due diligence process takes time, but it pales in comparison to the cost of a compliance violation or a year of poor lead quality. Start by assembling a small team (operations, compliance, and sales) to review each vendor against the checklist. Assign owners to specific items, such as requesting references or reviewing consent documentation, and set deadlines for completion. Keep a written record of your findings for each vendor, including any red flags and how they were resolved.

Remember that due diligence is not a one-time event. Even after you sign a contract, continue to monitor lead quality, compliance documentation, and vendor performance. Schedule quarterly reviews to ensure the vendor remains in good standing and that your success criteria are still being met. If performance slips or compliance issues arise, act quickly to address them or transition to a new vendor.

By following this checklist, your agency can build a reliable, compliant pipeline of Medicare leads while minimizing risk and maximizing return on investment. The right vendor becomes a true partner in your growth, and the wrong one becomes a cautionary tale. Choose wisely, document everything, and never let urgency override diligence.